Advanced Biomed Inc Increase (Decrease) in Other Noncurrent Assets
Advanced Biomed Inc (ADVB) reported Increase (Decrease) in Other Noncurrent Assets of -$2.95 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-05-15
- Advanced Biomed Inc increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$1.30K.
- Advanced Biomed Inc increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $6.61K.
- Advanced Biomed Inc increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$8.26K.
- Advanced Biomed Inc increase (decrease) in other noncurrent assets for the quarter ending 2024-06-30 was -$9.55K.
- Advanced Biomed Inc increase (decrease) in other noncurrent assets for fiscal 2025 was $83.03K.
- Advanced Biomed Inc increase (decrease) in other noncurrent assets for fiscal 2024 was -$56.13K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$1.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $5.31K derived: sum of 2 quarters · filed 2026-05-15 | -$2.95K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $6.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$1.65K 10-Q · filed 2026-02-13 | ||
| 2025-09-30 | -$8.26K 10-Q · filed 2025-11-19 | |||
| 2025-06-30 | $83.03K 10-K · filed 2025-10-08 | |||
| 2024-06-30 | -$9.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$9.96K derived: sum of 2 quarters · filed 2025-10-08 | -$56.13K 10-K · filed 2025-10-08 | |
| 2024-03-31 | -$409.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | -$46.57K 10-Q · filed 2025-05-15 | ||
| 2023-12-31 | -$46.16K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |